Literature DB >> 31597772

PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.

Nathaniel Edward Bennett Saidu1, Vedrana Filić2, Miranda Thomas3, Vanessa Sarabia-Vega3, Anamaria Đukić1, Frane Miljković1, Lawrence Banks3, Vjekoslav Tomaić4.   

Abstract

Cancer-causing human papillomavirus (HPV) E6 oncoproteins have a class I PDZ-binding motif (PBM) on their C termini, which play critical roles that are related to the HPV life cycle and HPV-induced malignancies. E6 oncoproteins use these PBMs to interact with, to target for proteasome-mediated degradation, a plethora of cellular substrates that contain PDZ domains and that are involved in the regulation of various cellular pathways. In this study, we show that both HPV-16 and HPV-18 E6 oncoproteins can interact with Na+/H+ exchange regulatory factor 2 (NHERF-2), a PDZ domain-containing protein, which among other cellular functions also behaves as a tumor suppressor regulating endothelial proliferation. The interaction between the E6 oncoproteins and NHERF-2 is PBM dependent and results in proteasome-mediated degradation of NHERF-2. We further confirmed this effect in cells derived from HPV-16- and HPV-18-positive cervical tumors, where we show that NHERF-2 protein turnover is increased in the presence of E6. Finally, our data indicate that E6-mediated NHERF-2 degradation results in p27 downregulation and cyclin D1 upregulation, leading to accelerated cellular proliferation. To our knowledge, this is the first report to demonstrate that E6 oncoproteins can stimulate cell proliferation by indirectly regulating p27 through targeting a PDZ domain-containing protein.IMPORTANCE This study links HPV-16 and HPV-18 E6 oncoproteins to the modulation of cellular proliferation. The PDZ domain-containing protein NHERF-2 is a tumor suppressor that has been shown to regulate endothelial proliferation; here, we demonstrate that NHERF-2 is targeted by HPV E6 for proteasome-mediated degradation. Interestingly, this indirectly affects p27, cyclin D1, and CDK4 protein levels and, consequently, affects cell proliferation. Hence, this study provides information that will improve our understanding of the molecular basis for HPV E6 function, and it also highlights the importance of the PDZ domain-containing protein NHERF-2 and its tumor-suppressive role in regulating cell proliferation.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  E6 oncoprotein; HPV; NHERF-2; cell proliferation; cervical cancer; cyclin D1; p27

Mesh:

Substances:

Year:  2019        PMID: 31597772      PMCID: PMC6912117          DOI: 10.1128/JVI.00663-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31.

Authors:  Choongho Lee; Laimonis A Laimins
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

2.  NHERF-2 maintains endothelial homeostasis.

Authors:  Resham Bhattacharya; Enfeng Wang; Shamit K Dutta; Pawan K Vohra; Guangqi E; Y S Prakash; Debabrata Mukhopadhyay
Journal:  Blood       Date:  2012-02-17       Impact factor: 22.113

3.  E6 and E7 from human papillomavirus type 16 cooperate to target the PDZ protein Na/H exchange regulatory factor 1.

Authors:  Rosita Accardi; Rosa Rubino; Mariafrancesca Scalise; Tarik Gheit; Naveed Shahzad; Miranda Thomas; Lawrence Banks; Cesare Indiveri; Bakary S Sylla; Rosa A Cardone; Stephan J Reshkin; Massimo Tommasino
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

4.  The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7.

Authors:  Anita Szalmás; Vjekoslav Tomaić; Om Basukala; Paola Massimi; Suruchi Mittal; József Kónya; Lawrence Banks
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

5.  Identification of a novel activity of human papillomavirus type 16 E6 protein in deregulating the G1/S transition.

Authors:  Ilaria Malanchi; Sandra Caldeira; Maja Krützfeldt; Marianna Giarre; Marianna Alunni-Fabbroni; Massimo Tommasino
Journal:  Oncogene       Date:  2002-08-22       Impact factor: 9.867

6.  Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators.

Authors:  V Tomaić; D Gardiol; P Massimi; M Ozbun; M Myers; L Banks
Journal:  Oncogene       Date:  2008-09-29       Impact factor: 9.867

7.  Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis.

Authors:  Rebeccah R Riley; Stefan Duensing; Tiffany Brake; Karl Münger; Paul F Lambert; Jeffrey M Arbeit
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

8.  The human papillomavirus (HPV) E6* proteins from high-risk, mucosal HPVs can direct degradation of cellular proteins in the absence of full-length E6 protein.

Authors:  David Pim; Vjekoslav Tomaic; Lawrence Banks
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

9.  Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes.

Authors:  Richard A Watson; Miranda Thomas; Lawrence Banks; Sally Roberts
Journal:  J Cell Sci       Date:  2003-12-15       Impact factor: 5.285

Review 10.  Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites.

Authors:  Vjekoslav Tomaić
Journal:  Cancers (Basel)       Date:  2016-10-19       Impact factor: 6.639

View more
  4 in total

Review 1.  Molecular Mechanisms of HIV Protease Inhibitors Against HPV-Associated Cervical Cancer: Restoration of TP53 Tumour Suppressor Activities.

Authors:  Lilian Makgoo; Salerwe Mosebi; Zukile Mbita
Journal:  Front Mol Biosci       Date:  2022-05-10

2.  ATP synthase modulation leads to an increase of spare respiratory capacity in HPV associated cancers.

Authors:  Matthias Kirschberg; Sandra Heuser; Gian Paolo Marcuzzi; Martin Hufbauer; Jens Michael Seeger; Anamaria Đukić; Vjekoslav Tomaić; Slawomir Majewski; Steffen Wagner; Claus Wittekindt; Nora Würdemann; Jens Peter Klussmann; Alexander Quaas; Hamid Kashkar; Baki Akgül
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

Review 3.  Human Papillomaviruses-Associated Cancers: An Update of Current Knowledge.

Authors:  Ena Pešut; Anamaria Đukić; Lucija Lulić; Josipa Skelin; Ivana Šimić; Nina Milutin Gašperov; Vjekoslav Tomaić; Ivan Sabol; Magdalena Grce
Journal:  Viruses       Date:  2021-11-06       Impact factor: 5.048

Review 4.  Targeting PDZ domains as potential treatment for viral infections, neurodegeneration and cancer.

Authors:  Caterina Nardella; Lorenzo Visconti; Francesca Malagrinò; Livia Pagano; Marianna Bufano; Marianna Nalli; Antonio Coluccia; Giuseppe La Regina; Romano Silvestri; Stefano Gianni; Angelo Toto
Journal:  Biol Direct       Date:  2021-10-12       Impact factor: 4.540

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.